High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS-Reference-Cited by-同舟云学术

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS

Published:2021-04-13 Issue:9 Volume:17 Page:3230-3238
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Tozer Sarah J.¹²^ORCID,Smith Helen V.³^ORCID,Whiley David M.¹²^ORCID,Borrow Ray⁴^ORCID,Boccadifuoco Giuseppe⁵^ORCID,Medini Duccio⁵^ORCID,Serruto Davide⁵^ORCID,Giuliani Marzia Monica⁵^ORCID,Stella Maria⁵^ORCID,De Paola Rosita⁵^ORCID,Muzzi Alessandro⁵^ORCID,Pizza Mariagrazia⁵^ORCID,Sloots Theo P.¹²^ORCID,Nissen Michael D.¹²⁶^ORCID

Affiliation:

1. Queensland Paediatric Infectious Disease Laboratory, Children’s Health Queensland Hospitals and Health Service, Queensland Children’s Hospital, Brisbane, Australia

2. Child Health Research Centre, The University of Queensland, Brisbane, Australia

3. Pathology Queensland, Forensic & Scientific Services, Brisbane, Australia

4. Public Health England, Meningococcal Reference Unit, Manchester Royal Infirmary, Manchester, United Kingdom

5. GSK, Siena, Italy

6. GSK, Melbourne, Australia

Funder

GlaxoSmithKline Biologicals

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1904758

Reference38 articles.

1. The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

2. Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination

3. Australian Government- Department of Health. Invasive meningococcal disease national surveillance report - 1 January to 30 June 2019. [accessed 2020 Apr 20]. http://www1.health.gov.au/internet/main/publishing.nsf/Content/5FEABC4B495BDEC1CA25807D001327FA/$File/IMD-surveil-report-Jan-June-2019.pdf.

4. Australian Government- Department of Health. Invasive meningococcal disease national surveillance report – 1 October to 31 December 2018. [accessed 2020 Apr 20]. http://www1.health.gov.au/internet/main/publishing.nsf/Content/5FEABC4B495BDEC1CA25807D001327FA/$File/1Oct-31Dec19-qrt3-IMD.pdf.

5. Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016–2019 and coverage vaccine prediction;Vaccine;2024-12

2. Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010–2014;Human Vaccines & Immunotherapeutics;2024-07-22

3. 4CMenB journey to the 10-year anniversary and beyond;Human Vaccines & Immunotherapeutics;2024-07-08

4. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020;mSphere;2024-06-25

5. Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness;Expert Review of Vaccines;2023-08-25